The crystal structure of human α1-tryptase reveals a blocked substrate-binding region

Journal of Molecular Biology

Volumn 321, Issue 3, 2002, Pages 491-502

  Marquardt, Ulf ^a   Zettl, Frank ^b   Huber, Robert ^a   Bode, Wolfram ^a   Sommerhoff, Christian P ^b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Allergy; Asthma; Mast cells; Tryptase; X ray crystallography

Indexed keywords

ALPHA1 TRYPTASE; ASPARTIC ACID; BETA2 TRYPTASE; GLYCINE; HEPARIN; SERINE; TRYPTASE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; ENZYME BINDING; ENZYME CONFORMATION; ENZYME DEGRADATION; ENZYME MECHANISM; ENZYME STABILITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; PRIORITY JOURNAL; PROTEIN PROCESSING; X RAY CRYSTALLOGRAPHY;

EID: 0036385841     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)00625-3     Document Type: Article

References (49)

1. Miller, J. S., Westin, E. H. & Schwartz, L. B. (1989). Cloning and characterization of complementary DNA for human tryptase. J. Clin. Invest. 84, 1188-1195.
2. Pallaoro, M., Fejzo, M. S., Shayesteh, L., Blount, J. L. & Caughey, G. H. (1999). Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. J. Biol. Chem. 274, 3355-3362.
3. Caughey, G. H., Raymond, W. W., Blount, J. L., Hau, L. W., Pallaoro, M., Wolters, P. J. & Verghese, G. M. (2000). Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families. J. Immunol. 164, 6566-6575.
4. Miller, J. S., Moxley, G. & Schwartz, L. B. (1990). Cloning and characterization of a second complementary DNA for human tryptase. J. Clin. Invest. 86, 864-870.
5. Vanderslice, P., Ballinger, S. M., Tam, E. K., Goldstein, S. M., Craik, C. S. & Caughey, G. H. (1990). Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc. Natl Acad. Sci. USA, 87, 3811-3815.
6. Wong, G. W., Tang, Y. & Stevens, R. L. (1999). Cloning of the human homolog of mouse transmembrane tryptase. Int. Arch. Allergy Immunol. 118, 419-421.
7. Wong, G. W., Tang, Y., Feyfant, E., Sali, A., Li, L., Li, Y. et al. (1999). Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension. J. Biol. Chem. 274, 30784-30793.
8. Schwartz, L. B., Foley, J. V., Austen, K. F., Soter, N. A., Shepard, R. & Murphy, G. F. (1985). Localization of tryptase to human cutaneous mast cells and keratinocytes by immunofluorescence and immunoperoxidase cytochemistry with monoclonal antitryptase antibody. J. Allergy Clin. Immunol. 76, 182-188.
9. Sakai, K., Ren, S. & Schwartz, L. B. (1996). A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J. Clin. Invest. 97, 988-995.
10. Lohi, J., Harvima, I. & Keski-Oja, J. (1992). Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J. Cell. Biochem. 50, 337-349.
11. Little, S. S. & Johnson, D. A. (1995). Human mast cell tryptase isoforms: separation and examination of substrate-specificity differences. Biochem. J. 307, 341-346.
12. Schwartz, L. B., Bradford, T. R., Littman, B. H. & Wintroub, B. U. (1985). The fibrinogenolytic activity of purified tryptase from human lung mast cells. J. Immunol. 135, 2762-2767.
13. Schechter, N. M., Brass, L. F., Lavker, R. M. & Jensen, P. J. (1998). Reaction of mast cell proteases tryptase and chymase with protease-activated receptors (PARs) on keratinocytes and fibroblasts. J. Cell. Physiol. 176, 365-373.
14. Johnson, P. R., Ammit, A. J., Carlin, S. M., Armour, C. L., Caughey, G. H. & Black, J. L. (1997). Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus. Eur. Respir. J. 10, 38-43.
15. Harris, J. L., Niles, A., Burdick, K., Maffitt, M., Backes, B. J., Ellman, J. A. et al. (2001). Definition of the extended substrate specificity determinants for β-tryptases I and II. J. Biol. Chem. 276, 34941-34947.
16. Kam, C. M., Hernandez, M. A., Patil, G. S., Ueda, T., Simmons, W. H., Braganza, V. J. & Powers, J. C. (1995). Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitors. Arch. Biochem. Biophys. 316, 808-814.
17. Sommerhoff, C. P., Bode, W., Pereira, P. J., Stubbs, M. T., Sturzebecher, J., Piechottka, G. P. et al. (1999). The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. Proc. Natl Acad. Sci. USA, 96, 10984-10991.
18. Pereira, P. J., Bergner, A., Macedo-Ribeiro, S., Huber, R., Matschiner, G., Fritz, H. et al. (1998). Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature, 392, 306-311.
19. Schwartz, L. B., Sakai, K., Bradford, T. R., Ren, S., Zweiman, B., Worobec, A. S. & Metcalfe, D. D. (1995). The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J. Clin. Invest. 96, 2702-2710.
20. Xia, H. Z., Kepley, C. L., Sakai, K., Chelliah, J., Irani, A. M. & Schwartz, L. B. (1995). Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J. Immunol. 154, 5472-5480.
21. Schwartz, H. J. (1995). Elevated serum tryptase in exercise-induced anaphylaxis. J. Allergy Clin. Immunol. 95, 917-919.
22. Kanthawatana, S., Carias, K., Arnaout, R., Hu, J., Irani, A. M. & Schwartz, L. B. (1999). The potential clinical utility of serum alpha-protryptase levels. J. Allergy Clin. Immunol. 103, 1092-1099.
23. Huang, C., Li, L., Krilis, S. A., Chanasyk, K., Tang, Y., Li, Z. et al. (1999). Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft. J. Biol. Chem. 274, 19670-19676.
24. Bode, W. (1979). Activation, activity and inhibition of bovine trypsin. Naturwissenschaften, 66, 251-258.
25. Huang, C., Morales, G., Vagi, A., Chanasyk, K., Ferrazzi, M., Burklow, C. et al. (2000). Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases. Dependence on a conserved Trp-rich domain on the surface. J. Biol. Chem. 275, 351-358.
26. Stubbs, M. T., Morenweiser, R., Sturzebecher, J., Bauer, M., Bode, W., Huber, R. et al. (1997). The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition. J. Biol. Chem. 272, 19931-19937.
27. Bode, W., Meyer, E., Jr & Powers, J. C. (1989). Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry, 28, 1951-1963.
28. Bode, W. (1979). The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. II. The binding of the pancreatic trypsin inhibitor and of isoleucine-valine and of sequentially related peptides to trypsinogen and to p-guanidinobenzoate-trypsinogen. J. Mol. Biol. 127, 357-374.
29. Selwood, T., Wang, Z. M., McCaslin, D. R. & Schechter, N. M. (2002). Diverse stability and catalytic properties of human tryptase alpha and beta isoforms are mediated by residue. Biochemistry, 41, 3329-3340.
30. Lutzelschwab, C., Pejler, G., Aveskogh, M. & Hellman, L. (1997). Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations. J. Expt. Med. 185, 13-29.
31. Sommerhoff, C. P., Bode, W., Matschiner, G., Bergner, A. & Fritz, H. (2000). The human mast cell tryptase tetramer: a fascinating riddle solved by structure. Biochim. Biophys. Acta, 1477, 75-89.
32. Schaschke, N., Matschiner, G., Zettl, F., Marquardt, U., Bergner, A., Bode, W. et al. (2001). Bivalent inhibition of human beta-tryptase. Chem. Biol. 8, 313-327.
33. Rice, K. D., Wang, V. R., Gangloff, A. R., Kuo, E. Y., Dener, J. M., Newcomb, W. S. et al. (2000). Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity. Bioorg. Med. Chem. Letters, 10, 2361-2366.
34. Rice, K. D., Gangloff, A. R., Kuo, E. Y., Dener, J. M., Wang, V. R., Lum, R. et al. (2000). Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors. Bioorg. Med. Chem. Letters, 10, 2357-2360.
35. Sommerhoff, C. P., Zettl, F., Hoehneke, C. & Gabrijelcic-Geiger, D. (2002). Expression of recombinant human mast cell tryptases. J. Biol. Chem. In the Press.
36. Matthews, B. W. (1968). Solvent content of protein crystals. J. Mol. Biol. 33, 491-497.
37. Collaborative Computational Project, N. (1994). The CCP4 suite: programs for crystallography. Acta Crystallog. sect. D, 50, 157-163.
38. Navaza, J., Panepucci, E. H. & Martin, C. (1998). On the use of strong Patterson function signals in many-body molecular replacement. Acta Crystallog. Biol. Crystallog. sect. D, 54, 817-821.
39. Turk, D. (1992). Weiterentwicklung eines Programmes für Molekülgrafik und Elektronendichte-Manipulation und seine Anwendung auf verschiedene Protein-Strukturaufklärungen. PhD Thesis, Technische Universität München, Germany
40. Brünger, A. T., Adams, P. D., Clore, G. M., Delano, W. L., Gros, P., Grossekunstleve, R. W. et al. (1998). Crystallography and NMR system - a new software suite for macromolecular structure determination. Acta Crystallog. sect. D, 54, 906-921.
41. Adams, P. D., Pannu, N. S., Read, R. J. & Brünger, A. T. (1997). Cross-validated maximum likelihood enhances crystallographic simulated annealing refinement. Proc. Natl Acad. Sci. USA, 94, 5018-5023.
42. Engh, R. & Huber, R. (1991). Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallog. sect. A, 47, 392-400.
43. Laskowski, R. A., MacArthur, M. W. & Thornton, J. M. (1998). Validation of protein models derived from experiment. Curr. Opin. Struct. Biol. 8, 631-639.
44. Ramachandran, G. N. & Sasisekharan, V. (1968). Conformation of polypeptides and proteins. Advan. Protein Chem. 23, 283-437.
45. Kraulis, P. J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24, 946-950.
46. Merritt, E. A. & Bacon, D. J. (1997). Raster3D photo-realistic molecular graphics. Methods Enzymol. 277, 505-527.
47. Nicholls, A., Bharadwaj, R. & Honig, B. (1993). Grasp: graphical representation and analysis of surface properties. Biophys. J. 64, A166.
48. Kabsch, W. & Sander, C. (1983). Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers, 22, 2577-2637.
49. Barton, G. J. (1993). ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng. 6, 37-40.